# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
JP Morgan analyst Brian Ossenbeck maintains ArcBest (NASDAQ:ARCB) with a Neutral and lowers the price target from $134 to $133.
TD Cowen analyst Jason Seidl maintains ArcBest (NASDAQ:ARCB) with a Buy and lowers the price target from $136 to $131.
Stephens & Co. analyst Daniel Imbro reiterates ArcBest (NASDAQ:ARCB) with a Overweight and maintains $130 price target.
Wells Fargo analyst Christian Wetherbee downgrades ArcBest (NASDAQ:ARCB) from Overweight to Equal-Weight and lowers the pric...
B of A Securities analyst Ken Hoexter maintains ArcBest (NASDAQ:ARCB) with a Underperform and lowers the price target from $...
Stifel analyst J. Bruce Chan maintains ArcBest (NASDAQ:ARCB) with a Buy and lowers the price target from $150 to $131.
TD Cowen analyst Jason Seidl maintains ArcBest (NASDAQ:ARCB) with a Buy and lowers the price target from $148 to $136.